The Suppressive Effect of Mamiran Cream on Atopic Dermatitis-Like Skin Lesions In Vivo
Open Access
- 30 November 2021
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2021, 1-12
Abstract
Background. The Chinese herbal formula Mamiran cream (MMC) has been known for its ameliorative effects on diverse skin diseases, such as eczema. Atopic dermatitis (AD; eczema) is a chronic recurrent skin disease dominated by T-helper type 2-driven inflammation (Th2). Objective. In this study, the inhibitory effect of MMC on AD was investigated in vivo. Methods. An animal model was established by sensitization with 2,4-dinitrochlorobenzene (DNCB) on the skin of SD rats. Cutaneous administration of MMC was applied, and its mechanism of action was investigated via RT-PCR and IHC assay. Result. Our data showed that topical application of MMC reduced the skin severity scores and alleviated the histological changes. Furthermore, immunohistochemical analysis demonstrated that MMC significantly decreased the levels of Th2 cytokine IL-5 and IL-4Ra in the skin lesion. In addition, it was demonstrated that MMC downregulated the mRNA expression of TNF-α, IL-1β, IL-6, IL-10, and TLR4. Moreover, MMC inhibited the activation of NF-κB, JNK1, and STAT6 pathways in skin lesions. Conclusions. Our findings suggest that MMC exhibits the inhibitory effect on AD, suggesting that MMC may be a potential therapeutic agent for this atopic disorder.Keywords
Funding Information
- National Key R&D Program of China (2020YFE0205600, 2020-JCTD-001, 2018Q007)
- West Light Foundation, Chinese Academy of Sciences (2020YFE0205600, 2020-JCTD-001, 2018Q007)
- Tianshan Youth Project of Xinjiang Uyghur Autonomous Region (2020YFE0205600, 2020-JCTD-001, 2018Q007)
This publication has 40 references indexed in Scilit:
- Abnormal epidermal barrier in the pathogenesis of contact dermatitisClinics in Dermatology, 2012
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulationImmunological Reviews, 2011
- Atopic dermatitis - from new pathophysiologic insights to individualized therapyAllergy, 2011
- Guidelines for management of atopic dermatitisThe Journal of Dermatology, 2009
- In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortexJournal of Clinical Virology, 2008
- Anti-inflammatory effects of Radix Gentianae Macrophyllae (Qinjiao), Rhizoma Coptidis (Huanglian) and Citri Unshiu Pericarpium (Wenzhou migan) in animal modelsChinese Medicine, 2008
- The prevalence of atopic triad in children with physician-confirmed atopic dermatitisJournal of the American Academy of Dermatology, 2008
- Coptidis rhizoma extract protects against cytokine-induced death of pancreatic β-cells through suppression of NF-κ B activationExperimental & Molecular Medicine, 2007
- Compounds from rose (Rosa rugosa) flowers with human immunodeficiency virus type 1 reverse transcriptase inhibitory activityJournal of Pharmacy and Pharmacology, 2006
- Atopic dermatitis and the atopic marchJournal of Allergy and Clinical Immunology, 2003